Read More 1 minute read Analyst Ratings News Price Target JMP Securities Maintains Market Outperform on Confluent, Lowers Price Target to $33 By Benzinga Newsdesk January 27, 8:43 AM JMP Securities analyst Patrick Walravens maintains Confluent (NASDAQ:CFLT) with a Market Outperform and lowers the price target from $45 to $33. CFLT
Read More 1 minute read Analyst Ratings Initiation News Price Target Guggenheim Initiates Coverage On Confluent with Buy Rating, Announces Price Target of $29 By Benzinga Newsdesk January 27, 5:58 AM Guggenheim analyst Howard Ma initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces Price Target of $29. CFLT
Read More 1 minute read Analyst Ratings News Price Target Upgrades Deutsche Bank Upgrades Confluent to Buy, Lowers Price Target to $28 By Benzinga Newsdesk January 23, 5:59 AM Deutsche Bank analyst Brad Zelnick upgrades Confluent (NASDAQ:CFLT) from Hold to Buy and lowers the price target from $32 to $28. CFLT
Read More 1 minute read Analyst Ratings Initiation News Price Target FBN Securities Initiates Coverage On Confluent with Outperform Rating, Announces Price Target of $30 By Benzinga Newsdesk January 17, 11:13 AM FBN Securities analyst Shebly Seyrafi initiates coverage on Confluent (NASDAQ:CFLT) with a Outperform rating and announces Price Target of $30. CFLT
Read More 22 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For January 10, 2023 By Benzinga Insights January 10, 11:01 AM Upgrades Morgan Stanley upgraded the previous rating for Stem Inc (NYSE:STEM) from Equal-Weight to Overweight. In the third… A
Read More 2 minute read Analyst Ratings Analyst Expectations for Confluent’s Future By Benzinga Insights January 10, 8:00 AM Over the past 3 months, 12 analysts have published their opinion on Confluent (NASDAQ:CFLT) stock. These analysts are… CFLT
Read More 20 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023 By Benzinga Insights January 6, 11:00 AM Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics… AGTI
Read More 1 minute read Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Confluent, Lowers Price Target to $36 By Benzinga Newsdesk January 6, 9:11 AM Wells Fargo analyst Michael Turrin maintains Confluent (NASDAQ:CFLT) with a Overweight and lowers the price target from $40 to $36. CFLT
Read More 1 minute read Analyst Ratings Downgrades News Price Target Scotiabank Downgrades Confluent to Sector Perform, Announces $21 Price Target By Benzinga Newsdesk January 6, 8:20 AM Scotiabank analyst Nick Altmann downgrades Confluent (NASDAQ:CFLT) from Sector Outperform to Sector Perform and announces $21 price target. CFLT
Read More 4 minute read Options 10 Information Technology Stocks Whale Activity In Today’s Session By Benzinga Insights January 5, 1:52 PM This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. AAPL